Pharmacogenetics and Genetic Polymorphism of CYP Enzymes in Indian Population: A Clinical Review
[...]the genetic variation at CYP1, CYP2C8, CYP3A4, CYP2C9, CYP2C19 and CYP2D6 was described at global as well as in India by genotyping new population samples and by collecting data from the literature. Altered activity variants occur in all geographic regions, reaching extremely high frequencies i...
Gespeichert in:
| Veröffentlicht in: | Research journal of pharmacy and technology 2018-12, Vol.11 (12), p.5681-5686 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5686 |
|---|---|
| container_issue | 12 |
| container_start_page | 5681 |
| container_title | Research journal of pharmacy and technology |
| container_volume | 11 |
| creator | Rajagopal, Shanmuga Sundaram Varghese, Anila A Kandasamy, Krishnaveni Sukumaran, Bhavatharini |
| description | [...]the genetic variation at CYP1, CYP2C8, CYP3A4, CYP2C9, CYP2C19 and CYP2D6 was described at global as well as in India by genotyping new population samples and by collecting data from the literature. Altered activity variants occur in all geographic regions, reaching extremely high frequencies in some populations, which has many important clinical consequences; each of the CYP genes studied shows a distinct geographic pattern of variation reflecting past evolutionary processes; effect of demography on pharmacogenetic variation should be also considered at themicro geographic scale; and several geographic regions of pharmacogenetic interest are still poorly characterized. Li Y, Millikan RC, Bell DA, Cui L, TseCh-KJ, Newman B, Conway K. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. AquilantecL, Langaee TY, Lopez Lm, Yarandi HN, Tromberg JS, Mohuczy D, et al., Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2c9 gene polymorphisms on warfarin dose requirements. |
| doi_str_mv | 10.5958/0974-360X.2018.01029.6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2193093470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2193093470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c145t-53af64d02ae8e7a3a053fac4726c457c023035f3554546c943baa8a2c3c8c2e73</originalsourceid><addsrcrecordid>eNo9kG9LwzAQh4MoOOa-ggR83ZnmX1vfjTJ1MHCIgr6KZ5a6jDapSafMT2_rZPfm7sc93MGD0GVKpqIQ-TUpMp4wSV6mlKT5lKSEFlN5gkbHxelxTvNzNIlxS_qSuaA8H6G31QZCA9p_GGc6qyMGt8Z3h4BXvt43PrQbGxvsK1y-rvDc_ewbE7F1eOHWFlxPtbsaOuvdDZ7hsrbOaqjxo_my5vsCnVVQRzP572P0fDt_Ku-T5cPdopwtE51y0SWCQSX5mlAwucmAARGsAs0zKjUXmSaUESYqJgQXXOqCs3eAHKhmOtfUZGyMrg532-A_dyZ2aut3wfUvFU0LRgrGM9JT8kDp4GMMplJtsA2EvUqJGoSqwZUavKlBqPoTqiT7BS1laG4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2193093470</pqid></control><display><type>article</type><title>Pharmacogenetics and Genetic Polymorphism of CYP Enzymes in Indian Population: A Clinical Review</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Rajagopal, Shanmuga Sundaram ; Varghese, Anila A ; Kandasamy, Krishnaveni ; Sukumaran, Bhavatharini</creator><creatorcontrib>Rajagopal, Shanmuga Sundaram ; Varghese, Anila A ; Kandasamy, Krishnaveni ; Sukumaran, Bhavatharini</creatorcontrib><description>[...]the genetic variation at CYP1, CYP2C8, CYP3A4, CYP2C9, CYP2C19 and CYP2D6 was described at global as well as in India by genotyping new population samples and by collecting data from the literature. Altered activity variants occur in all geographic regions, reaching extremely high frequencies in some populations, which has many important clinical consequences; each of the CYP genes studied shows a distinct geographic pattern of variation reflecting past evolutionary processes; effect of demography on pharmacogenetic variation should be also considered at themicro geographic scale; and several geographic regions of pharmacogenetic interest are still poorly characterized. Li Y, Millikan RC, Bell DA, Cui L, TseCh-KJ, Newman B, Conway K. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. AquilantecL, Langaee TY, Lopez Lm, Yarandi HN, Tromberg JS, Mohuczy D, et al., Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2c9 gene polymorphisms on warfarin dose requirements.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.5958/0974-360X.2018.01029.6</identifier><language>eng</language><publisher>Raipur: A&V Publications</publisher><subject>Anticoagulants ; Breast cancer ; Cytochrome ; Drug dosages ; Enzymes ; Gene expression ; Genotype & phenotype ; Haplotypes ; Hydrocarbons ; Lung cancer ; Metabolism ; Metabolites ; Mutation ; Polymorphism ; Population ; Studies</subject><ispartof>Research journal of pharmacy and technology, 2018-12, Vol.11 (12), p.5681-5686</ispartof><rights>Copyright A&V Publications Dec 2018</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Rajagopal, Shanmuga Sundaram</creatorcontrib><creatorcontrib>Varghese, Anila A</creatorcontrib><creatorcontrib>Kandasamy, Krishnaveni</creatorcontrib><creatorcontrib>Sukumaran, Bhavatharini</creatorcontrib><title>Pharmacogenetics and Genetic Polymorphism of CYP Enzymes in Indian Population: A Clinical Review</title><title>Research journal of pharmacy and technology</title><description>[...]the genetic variation at CYP1, CYP2C8, CYP3A4, CYP2C9, CYP2C19 and CYP2D6 was described at global as well as in India by genotyping new population samples and by collecting data from the literature. Altered activity variants occur in all geographic regions, reaching extremely high frequencies in some populations, which has many important clinical consequences; each of the CYP genes studied shows a distinct geographic pattern of variation reflecting past evolutionary processes; effect of demography on pharmacogenetic variation should be also considered at themicro geographic scale; and several geographic regions of pharmacogenetic interest are still poorly characterized. Li Y, Millikan RC, Bell DA, Cui L, TseCh-KJ, Newman B, Conway K. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. AquilantecL, Langaee TY, Lopez Lm, Yarandi HN, Tromberg JS, Mohuczy D, et al., Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2c9 gene polymorphisms on warfarin dose requirements.</description><subject>Anticoagulants</subject><subject>Breast cancer</subject><subject>Cytochrome</subject><subject>Drug dosages</subject><subject>Enzymes</subject><subject>Gene expression</subject><subject>Genotype & phenotype</subject><subject>Haplotypes</subject><subject>Hydrocarbons</subject><subject>Lung cancer</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Mutation</subject><subject>Polymorphism</subject><subject>Population</subject><subject>Studies</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kG9LwzAQh4MoOOa-ggR83ZnmX1vfjTJ1MHCIgr6KZ5a6jDapSafMT2_rZPfm7sc93MGD0GVKpqIQ-TUpMp4wSV6mlKT5lKSEFlN5gkbHxelxTvNzNIlxS_qSuaA8H6G31QZCA9p_GGc6qyMGt8Z3h4BXvt43PrQbGxvsK1y-rvDc_ewbE7F1eOHWFlxPtbsaOuvdDZ7hsrbOaqjxo_my5vsCnVVQRzP572P0fDt_Ku-T5cPdopwtE51y0SWCQSX5mlAwucmAARGsAs0zKjUXmSaUESYqJgQXXOqCs3eAHKhmOtfUZGyMrg532-A_dyZ2aut3wfUvFU0LRgrGM9JT8kDp4GMMplJtsA2EvUqJGoSqwZUavKlBqPoTqiT7BS1laG4</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Rajagopal, Shanmuga Sundaram</creator><creator>Varghese, Anila A</creator><creator>Kandasamy, Krishnaveni</creator><creator>Sukumaran, Bhavatharini</creator><general>A&V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20181201</creationdate><title>Pharmacogenetics and Genetic Polymorphism of CYP Enzymes in Indian Population: A Clinical Review</title><author>Rajagopal, Shanmuga Sundaram ; Varghese, Anila A ; Kandasamy, Krishnaveni ; Sukumaran, Bhavatharini</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c145t-53af64d02ae8e7a3a053fac4726c457c023035f3554546c943baa8a2c3c8c2e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anticoagulants</topic><topic>Breast cancer</topic><topic>Cytochrome</topic><topic>Drug dosages</topic><topic>Enzymes</topic><topic>Gene expression</topic><topic>Genotype & phenotype</topic><topic>Haplotypes</topic><topic>Hydrocarbons</topic><topic>Lung cancer</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Mutation</topic><topic>Polymorphism</topic><topic>Population</topic><topic>Studies</topic><toplevel>online_resources</toplevel><creatorcontrib>Rajagopal, Shanmuga Sundaram</creatorcontrib><creatorcontrib>Varghese, Anila A</creatorcontrib><creatorcontrib>Kandasamy, Krishnaveni</creatorcontrib><creatorcontrib>Sukumaran, Bhavatharini</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science & Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rajagopal, Shanmuga Sundaram</au><au>Varghese, Anila A</au><au>Kandasamy, Krishnaveni</au><au>Sukumaran, Bhavatharini</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacogenetics and Genetic Polymorphism of CYP Enzymes in Indian Population: A Clinical Review</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2018-12-01</date><risdate>2018</risdate><volume>11</volume><issue>12</issue><spage>5681</spage><epage>5686</epage><pages>5681-5686</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>[...]the genetic variation at CYP1, CYP2C8, CYP3A4, CYP2C9, CYP2C19 and CYP2D6 was described at global as well as in India by genotyping new population samples and by collecting data from the literature. Altered activity variants occur in all geographic regions, reaching extremely high frequencies in some populations, which has many important clinical consequences; each of the CYP genes studied shows a distinct geographic pattern of variation reflecting past evolutionary processes; effect of demography on pharmacogenetic variation should be also considered at themicro geographic scale; and several geographic regions of pharmacogenetic interest are still poorly characterized. Li Y, Millikan RC, Bell DA, Cui L, TseCh-KJ, Newman B, Conway K. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. AquilantecL, Langaee TY, Lopez Lm, Yarandi HN, Tromberg JS, Mohuczy D, et al., Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2c9 gene polymorphisms on warfarin dose requirements.</abstract><cop>Raipur</cop><pub>A&V Publications</pub><doi>10.5958/0974-360X.2018.01029.6</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0974-3618 |
| ispartof | Research journal of pharmacy and technology, 2018-12, Vol.11 (12), p.5681-5686 |
| issn | 0974-3618 0974-360X 0974-306X |
| language | eng |
| recordid | cdi_proquest_journals_2193093470 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Anticoagulants Breast cancer Cytochrome Drug dosages Enzymes Gene expression Genotype & phenotype Haplotypes Hydrocarbons Lung cancer Metabolism Metabolites Mutation Polymorphism Population Studies |
| title | Pharmacogenetics and Genetic Polymorphism of CYP Enzymes in Indian Population: A Clinical Review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T13%3A46%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacogenetics%20and%20Genetic%20Polymorphism%20of%20CYP%20Enzymes%20in%20Indian%20Population:%20A%20Clinical%20Review&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Rajagopal,%20Shanmuga%20Sundaram&rft.date=2018-12-01&rft.volume=11&rft.issue=12&rft.spage=5681&rft.epage=5686&rft.pages=5681-5686&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.5958/0974-360X.2018.01029.6&rft_dat=%3Cproquest_cross%3E2193093470%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2193093470&rft_id=info:pmid/&rfr_iscdi=true |